Biosimilars to Raise Unique Questions
Pfizer Announces Medicare Reimbursement for Inflectra (infliximab-dyyb), the First Biosimilar Monoclonal Antibody Available in the United States
- Connect with us:
Simple Tasks
Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.
Rheumatology Research Foundation
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
ACR/ARP Annual Meeting
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.